MEM 2025, page-129

There is a lot of great news due on the horizon for MEM. IMO, that news is near and will have a significant impact on the share price.

For example, in the last Quarterly (Oct 2024) MEM mentions that the Monash IVF trial results could arrive by end of year 2024. That didn't occur, but it does indicate that the news is likely very near.


Also, in the same Quarterly (Oct 2024), MEM mentions the task of working to achieve full market penetration in Japan once the Monash IVF trial is complete (the trial is now complete, and i believe achieving full market penetration in Japan means achieving insurance coverage for the Felix system in Japan, which would then allow all IVF clinics [private and public] to use the Felix system). So progress on this front could be due at any moment also.




Also, i think the Heranova Chinese clinical trial will be completed very quickly, as from memory, the trial is limited in scope and with such a huge population in China, i dare say that there will be plenty of patients available for participation in the trial (was the trial for 50 patients only.??). So news on this front could be relatively near also.

As others have mentioned, there is a chance that we could also hear some news relating to a partnership agreement or funding deal, which could be huge also.

The above mentioned does not even cover anywhere near all the possibilities, as MEM are currently working on multiple fronts to build the business and to build opportunities, so the message here is that there exists massive potential for big news to hit at any moment, and hence, there exists massive potential for a share price catalyst to drop at any moment too.

IMO, it won't be long......